Skip to main content
. 2016 Aug 10;68(3):726–735. doi: 10.1161/HYPERTENSIONAHA.116.07911

Figure 4.

Figure 4.

Genomic and nongenomic pathways of vascular mineralocorticoid receptor (MR) activity after isoproterenol treatment. Nuclear translocation of MR (A), mRNA expression of osteopontin (B), and protein expression of γ-epithelial sodium channel (γENaC; C), Src (D), and ERK1/2 (E) phosphorylation in thoracic aorta of control (CT) and isoproterenol (ISO) groups without or with spironolactone (SPI) treatment. Data represent mean±SEM; number of animals used in each group is indicated into the bars. Two-way ANOVA: P<0.05 *vs CT; #vs ISO.